Darren Charlton Smith, Group Chief Financial Officer at Telix Pharmaceuticals, bought TLX on Sep 7, 2026
Data as of Oct 16
▲ BUY$20K2,071 shares at $9.66Darren Charlton Smith Group Chief Financial OfficerTLX Telix Pharmaceuticals Ltd
- Traded
- Sep 7, 2026
- Disclosed
- Sep 14, 2026
- Filed
- 7 days after the trade · late
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
TLX since disclosure
−9.3%
Similar stocks (XLV) since disclosure
+5.3%
XLV — its sector index fund
Change in closing price from Sep 14, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.